Open

Coming up

Don't miss

Replay


LATEST SHOWS

THE BUSINESS INTERVIEW

The 'Stagnation Trap', with Catherine Mann, Chief Economist at OECD

Read more

ENCORE!

'An American in Paris', a truly transatlantic collaboration

Read more

BUSINESS DAILY

Oil prices 'could fall further' without OPEC output cut

Read more

IN THE PAPERS

How not to argue over Thanksgiving dinner

Read more

IN THE PAPERS

Just how green is François Hollande?

Read more

WEB NEWS

USA: African Americans call for boycott of 'Black Friday'

Read more

AFRICA NEWS

Sierra Leone: UN won't meet December 1st target for containing Ebola virus

Read more

MEDIAWATCH

Sarkozy criticised for comments about former justice minister's origins

Read more

INSIDE THE AMERICAS

Mexico kidnappings: Mother speaks out over missing daughter

Read more

Americas

Obama earmarks $1.8 billion for fight against pandemic

Text by NEWS WIRES

Latest update : 2009-07-16

US President Barack Obama has designated more than $1.8 billion in emergency funds to fight a pandemic of influenza A(H1N1), or swine flu. The money will mainly go toward producing vaccines and helping plan immunisation campaigns.

REUTERS - President Barack Obama designated $1.825 billion on Thursday for emergency use to fight the new pandemic of H1N1 swine flu.

 

The money will go to buy vaccine ingredients, to help health officials plan immunization campaigns and to help get the vaccines approved at the U.S. Food and Drug Administration, Obama said in a letter to House of Representatives Speaker Nancy Pelosi.

 

"To enhance our nation's capability to respond to the potential spread of this outbreak, and in accordance with the appropriation, I hereby designate $1.825 billion of the contingent appropriation as emergency funds required to address critical needs related to emerging influenza viruses (specifically, the virus known as 2009-H1N1)," Obama wrote.

 

The money comes from $7.65 billion Congress already appropriated to the Department of Health and Human Services for the swine flu pandemic.

 

The World Health Organization said earlier on Thursday that the H1N1 flu pandemic was the fastest-moving ever and that it was now pointless to count every case.

 

WHO said at least 50 governments have placed orders for vaccines and WHO vaccine chief Marie-Paule Kieny told Reuters the potential global value of the market was estimated at between $10 billion and $20 billion.

 

 Sanofi-Aventis, Novartis, Baxter, GlaxoSmithKline, and AstraZeneca's MedImmune unit all have H1N1 vaccines for the U.S. market.

 

Date created : 2009-07-16

COMMENT(S)